×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Cell Lysis Disruption Market Trends

ID: MRFR/HC/6886-HCR
111 Pages
Rahul Gotadki
October 2025

Cell Lysis and Disruption Market Research Report Information By Technique (Reagent Based, Physical Disruption), Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells) and End-User (Research Laboratories and Institutes) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Cell Lysis Disruption Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Cell Lysis Disruption Market

The changes brought about by technological advancements in life sciences studies coupled with the rising demand for biopharmaceuticals and personalized medicine have led to significant trends in cell lysis and disruption market. Cell lysis and disruption techniques have found a place in many applications that include genomics, proteomics, cell-based assays among others. More efficient methods of destroying cells have been sought following an enhanced understanding of cellular mechanisms. Therefore, intracellular contents like DNA, RNA proteins etc are set free through cell lysis and disruption as fundamental experiments on cellular function and science breakthroughs.

The face of the market has changed due to advancements in technology applied in lysing where new devices offer improved effectiveness; reliability; reproducibility; versatility etc., thus during cell disruption processes. Meanwhile mechanical bead milling or high pressure homogenization represent evolving homogenization methods whereas chemical or enzymatic lyses are some non-mechanical strategies being developed for researchers accordingly. At the same time automation and robotics are being employed in procedures involving this technique hence increased laboratory workflows standardization with capacity-enhancement.

The increased utilization of biologics and cell therapies in recent times has led to an increasing need for effective methods of breaking cells, which consequently release bioactive molecules. For large volume processing as well as maintaining product quality in a biopharmaceutical production, homogenization and ultrasonication techniques are especially appropriate. This is consistent with broader industry trends aimed at enhancing efficiency and optimization of bioprocessing.

This has led to a growing interest in precision medicine where cell lysis techniques have been adopted by scientists in order to understand disease mechanisms, identify biomarkers and develop targeted therapies. Diagnostic applications based on individual patient profiles require good cell disruption that retains molecule integrity than the one obtained from average ones.

To meet different stakeholders’ needs who often deal with vast number of cells types or sample sizes, modular and adaptive systems are being developed which allow one customizes speed, pressure, sample preparation etc as well. Life sciences applications can rely on this versatility of cell lysis solutions.

The fragmentation process may be employed together with sample preparations to increase efficiency while reducing analysis time. Such integrated systems include sample preparation; lysis and finally down stream analysis hence giving researchers a full package solution when either processing their samples or carrying out tests on them.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Cell Lysis and Disruption Market by 2035?

The projected market valuation for the Cell Lysis and Disruption Market is 17.3 USD Billion by 2035.

What was the market valuation of the Cell Lysis and Disruption Market in 2024?

The overall market valuation was 6.833 USD Billion in 2024.

What is the expected CAGR for the Cell Lysis and Disruption Market during the forecast period 2025 - 2035?

The expected CAGR for the Cell Lysis and Disruption Market during the forecast period 2025 - 2035 is 8.81%.

Which companies are considered key players in the Cell Lysis and Disruption Market?

Key players in the market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Qiagen, and Agilent Technologies.

What are the main techniques used in the Cell Lysis and Disruption Market?

The main techniques in the market include Reagent Based and Physical Disruption, with valuations of 8.5 and 8.8 USD Billion respectively by 2035.

Market Summary

As per MRFR analysis, the Cell Lysis and Disruption Market Size was estimated at 6.833 USD Billion in 2024. The Cell Lysis and Disruption industry is projected to grow from 7.435 USD Billion in 2025 to 17.3 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 8.81 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Cell Lysis and Disruption Market is experiencing robust growth driven by technological advancements and increasing demand for biopharmaceuticals.

  • Technological advancements in lysis methods are enhancing efficiency and effectiveness in cell disruption processes. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector. The reagent-based segment dominates the market, whereas the physical disruption segment is witnessing rapid growth. Rising research activities in biotechnology and the expansion of the pharmaceutical industry are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 6.833 (USD Billion)
2035 Market Size 17.3 (USD Billion)
CAGR (2025 - 2035) 8.81%
Largest Regional Market Share in 2024 Americas

Major Players

<p><a href="https://www.thermofisher.com/in/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/traditional-methods-cell-lysis.html">Thermo Fisher Scientific</a> (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Qiagen (NL), Agilent Technologies (US), GE Healthcare (GB), Becton, Dickinson and Company (US), Promega Corporation (US), Sartorius AG (DE)</p>

Market Trends

The Cell Lysis and Disruption Market is currently experiencing a notable evolution, driven by advancements in biotechnology and the increasing demand for efficient cell extraction techniques. This market encompasses a variety of methods and technologies aimed at breaking down cellular structures to release biomolecules for research and therapeutic applications. The growing focus on personalized medicine and the development of biologics are propelling the need for effective lysis solutions, as researchers seek to isolate proteins, nucleic acids, and other critical components from cells. Furthermore, the rise of synthetic biology and genomics is likely to enhance the relevance of this market, as innovative applications emerge that require precise and reliable cell disruption methods. In addition, the Cell Lysis and Disruption Market is influenced by the expanding biopharmaceutical sector, which necessitates robust and scalable lysis technologies. As companies strive to improve productivity and reduce costs, there is a shift towards automation and integration of lysis processes within larger workflows. This trend suggests a potential for increased collaboration between equipment manufacturers and end-users, fostering the development of tailored solutions that meet specific research needs. Overall, the market appears poised for growth, with ongoing research and development efforts likely to yield new methodologies and products that enhance the efficiency and effectiveness of cell lysis and disruption techniques.

Technological Advancements in Lysis Methods

Recent innovations in lysis technologies are transforming the Cell Lysis and Disruption Market. New methods, such as microfluidics and acoustic lysis, are emerging, offering enhanced efficiency and precision. These advancements enable researchers to achieve higher yields of target biomolecules while minimizing damage to sensitive cellular components.

Integration of Automation in Lysis Processes

The trend towards automation within laboratory workflows is becoming increasingly prominent in the Cell Lysis and Disruption Market. Automated systems streamline lysis procedures, reduce human error, and improve reproducibility. This shift is particularly beneficial for high-throughput applications, where efficiency and consistency are paramount.

Growing Demand for Biologics and Personalized Medicine

The rising interest in biologics and personalized medicine is significantly impacting the Cell Lysis and Disruption Market. As the focus on tailored therapies intensifies, the need for effective cell lysis techniques to extract and analyze biomolecules becomes more critical. This trend is likely to drive innovation and investment in lysis technologies.

Cell Lysis Disruption Market Market Drivers

Adoption of Advanced Lysis Technologies

The Cell Lysis and Disruption Market is increasingly characterized by the adoption of advanced lysis technologies, which are designed to improve efficiency and yield in cellular disruption processes. Innovations such as microfluidics, ultrasonic lysis, and enzymatic methods are gaining traction among researchers and manufacturers. These technologies not only enhance the extraction of cellular components but also reduce processing times and costs. As industries seek to streamline their operations and improve productivity, the demand for these advanced lysis solutions is likely to grow. This trend indicates a promising future for the Cell Lysis and Disruption Market, as it adapts to the evolving needs of various sectors, including pharmaceuticals, biotechnology, and academic research.

Increasing Focus on Genomics and Proteomics

The Cell Lysis and Disruption Market is witnessing a heightened focus on genomics and proteomics, which are critical fields in modern biological research. As the demand for high-throughput analysis of genetic material and proteins escalates, the need for efficient cell lysis techniques becomes paramount. The Cell Lysis and Disruption is projected to exceed 62 billion USD by 2026, reflecting a growing interest in personalized medicine and targeted therapies. This trend suggests that the Cell Lysis and Disruption Market will play a crucial role in supporting these initiatives by providing innovative lysis solutions that enhance the efficiency and accuracy of genomic and proteomic studies.

Rising Research Activities in Biotechnology

The Cell Lysis and Disruption Market is experiencing a surge in research activities, particularly within biotechnology sectors. This increase is driven by the need for advanced methodologies to extract cellular components for various applications, including drug development and genetic research. According to recent data, the biotechnology sector is projected to grow at a compound annual growth rate of approximately 7.4% over the next five years. This growth is likely to enhance the demand for efficient cell lysis techniques, as researchers seek to optimize their workflows and improve yield. Consequently, the Cell Lysis and Disruption Market stands to benefit from this trend, as innovative lysis solutions become essential for meeting the evolving needs of researchers and developers in the field.

Growing Applications in Environmental and Food Testing

The Cell Lysis and Disruption Market is expanding its reach into environmental and food testing applications, where the need for accurate analysis of microbial content is critical. As regulatory standards become more stringent, the demand for reliable lysis methods to detect pathogens and contaminants in food and environmental samples is increasing. This trend is supported by the rising awareness of food safety and environmental health, prompting industries to invest in advanced testing technologies. The market for food safety testing is projected to grow significantly, which may drive the demand for effective cell lysis solutions. Thus, the Cell Lysis and Disruption Market is likely to benefit from this diversification, as it provides essential tools for ensuring compliance and safety in these sectors.

Expansion of Pharmaceutical and Biopharmaceutical Industries

The Cell Lysis and Disruption Market is significantly influenced by the expansion of pharmaceutical and biopharmaceutical industries. As these sectors continue to grow, driven by increasing investments in drug discovery and development, the demand for effective cell lysis methods is expected to rise. The biopharmaceutical market alone is anticipated to reach a valuation of over 500 billion USD by 2026, indicating a robust growth trajectory. This expansion necessitates the use of advanced lysis technologies to facilitate the extraction of proteins, nucleic acids, and other biomolecules from cells. Therefore, the Cell Lysis and Disruption Market is poised to capitalize on this growth, providing essential tools and solutions to support the burgeoning pharmaceutical landscape.

Market Segment Insights

By Technique: Reagent Based (Largest) vs. Physical Disruption (Fastest-Growing)

<p>In the Cell Lysis and Disruption Market, the reagent-based technique holds the largest share, primarily due to its widespread application in various biotechnological and pharmaceutical contexts. This method leverages specific chemical reactions to effectively disrupt cell membranes, making it a preferred choice among researchers and laboratories. Physical disruption techniques, while currently smaller in market share, are gaining traction due to their ability to preserve biomolecules and deliver consistent results, thus appealing to emerging sectors like synthetic biology and personalized medicine.</p>

<p>Technique: Reagent Based (Dominant) vs. Physical Disruption (Emerging)</p>

<p>Reagent-based techniques dominate the Cell Lysis and Disruption Market as they offer selective lysis, which is crucial for applications in genomics, proteomics, and other molecular biology practices. They are known for their efficiency and versatility, catering to a broad range of sample types. On the other hand, physical disruption techniques, such as bead milling and sonication, are becoming increasingly popular, recognized for their ability to minimize contamination and maximize yield. This emerging trend is fueled by the growing demand for high-quality cellular material in biopharmaceutical processes, leading to innovations in equipment and methodologies that enhance the effectiveness of physical disruption.</p>

By Product: Consumables (Largest) vs. Instruments (Fastest-Growing)

<p>The Cell Lysis and Disruption Market is notably characterized by the dominance of consumables, which play a crucial role in the overall market share distribution. Consumables, including reagents and kits, constitute the largest segment as they are essential for various applications in molecular biology, diagnostics, and bioprocessing. This segment benefits from a recurring demand due to its consumable nature, driving consistent sales and market stability. In contrast, instruments hold a substantial value as well, representing the fastest-growing segment in this market. Their innovation and technological advancements support growth, attracting increased investments and market interest.</p>

<p>Consumables (Dominant) vs. Instruments (Emerging)</p>

<p>Consumables in the Cell Lysis and Disruption Market represent a dominant force due to their essentiality in laboratory settings, particularly in molecular biology applications. These products, including buffers and lysis reagents, are critical for efficient cell disruption and are utilized across various research and clinical laboratories. Their recurring purchase nature solidifies their market position. On the other hand, instruments are emerging as a significant segment, driven by innovations in technologies such as microfluidics and automation. These instruments offer enhanced precision and reproducibility, catering to the needs of modern research environments. As laboratories increasingly prioritize efficiency and automation, the instruments segment is poised for robust growth.</p>

By Cell Type: Mammalian Cells (Largest) vs. Microbial Cells (Fastest-Growing)

<p>In the Cell Lysis and Disruption Market, the segment of Mammalian Cells holds a significant market share, primarily driven by its extensive application in biopharmaceuticals and research laboratories. This segment is favored for its ability to facilitate the extraction of complex biomolecules efficiently, thus positioning it as the largest contributor to market dynamics. On the other hand, the Microbial Cells segment is witnessing rapid growth due to increasing applications in biotechnology, food, and agricultural sectors, making it a key player in this market.</p>

<p>Mammalian Cells (Dominant) vs. Microbial Cells (Emerging)</p>

<p>Mammalian Cells are often deemed the dominant force in the Cell Lysis and Disruption Market due to their crucial role in drug development and therapeutic production. These cells offer several advantages, including post-translational modifications that are essential for the efficacy of biopharmaceuticals. Conversely, Microbial Cells are emerging as a dynamic segment, driven by innovations in synthetic biology and fermentation processes. They are highly advantageous due to their rapid growth rates and the ability to produce complex proteins without the resource intensity of mammalian systems. This contrast highlights the strategic importance of both segments as they cater to different industrial needs.</p>

By End-User: Pharmaceutical and Biotechnology Companies (Largest) vs. Research Laboratories and Institutes (Fastest-Growing)

<p>In the Cell Lysis and Disruption Market, the distribution of market share among end-users reveals that pharmaceutical and biotechnology companies hold the largest share, driven by their extensive research and development activities. This segment capitalizes on advanced technologies for cell disruption to accelerate drug discovery and development processes. Conversely, research laboratories and institutes are noted as the fastest-growing segment, as they increasingly adopt lysis techniques for various scientific investigations, thereby expanding their market presence.</p>

<p>Pharmaceutical and Biotechnology Companies (Dominant) vs. Research Laboratories and Institutes (Emerging)</p>

<p>Pharmaceutical and biotechnology companies represent the dominant force in the cell lysis and disruption market due to their established infrastructure and focus on innovative therapies. Their investments in bioprocessing and clinical research drive the demand for efficient lysis techniques to extract crucial biomolecules. On the other hand, research laboratories and institutes serve as the emerging segment, as they are rapidly increasing their adoption of cell disruption technologies for experimental applications. This emerging segment benefits from collaborations with academic and industrial partners, leading to increased funding and resource allocation, thus strengthening their position in the market.</p>

Get more detailed insights about Cell Lysis and Disruption Market Research Report - Forecast till 2035

Regional Insights

Key Companies in the Cell Lysis Disruption Market market include

Industry Developments

  • Q2 2024: Thermo Fisher Scientific Launches New KingFisher Apex Purification System for Cell Lysis Applications Thermo Fisher Scientific announced the launch of its KingFisher Apex Purification System, designed to automate cell lysis and nucleic acid purification for research and clinical laboratories.
  • Q2 2024: Merck KGaA Opens New Bioprocessing Facility in Massachusetts to Expand Cell Lysis Reagent Production Merck KGaA inaugurated a new bioprocessing facility in Massachusetts, increasing its capacity for manufacturing cell lysis reagents used in biopharmaceutical production.
  • Q3 2024: QIAGEN Partners with Hamilton Robotics to Integrate Automated Cell Lysis Workflows QIAGEN announced a strategic partnership with Hamilton Robotics to co-develop automated cell lysis and sample preparation workflows for genomics and proteomics research.
  • Q3 2024: Beckman Coulter Life Sciences Acquires Cell Lysis Technology Startup LysiGen Beckman Coulter Life Sciences completed the acquisition of LysiGen, a startup specializing in advanced cell lysis technologies for single-cell analysis and bioprocessing.
  • Q4 2024: Promega Corporation Launches New Cell Lysis Buffer for High-Throughput Protein Extraction Promega Corporation introduced a new cell lysis buffer optimized for high-throughput protein extraction, targeting pharmaceutical and academic research labs.
  • Q4 2024: Sartorius AG Announces $100M Investment in Cell Lysis Instrument Manufacturing Expansion Sartorius AG revealed a $100 million investment to expand its manufacturing capabilities for cell lysis instruments at its Goettingen, Germany site.
  • Q1 2025: Thermo Fisher Scientific Receives CE Mark for New Cell Lysis Kit for Clinical Diagnostics Thermo Fisher Scientific received CE Mark approval for its latest cell lysis kit, enabling its use in clinical diagnostic laboratories across Europe.
  • Q1 2025: Bio-Rad Laboratories Appoints Dr. Lisa Chen as VP of Cell Lysis Product Development Bio-Rad Laboratories announced the appointment of Dr. Lisa Chen as Vice President of Cell Lysis Product Development, strengthening its leadership team in life sciences.
  • Q2 2025: Agilent Technologies Wins Major Contract to Supply Cell Lysis Systems to Leading Biotech Firm Agilent Technologies secured a multi-year contract to supply its cell lysis systems to a top biotechnology company for use in therapeutic protein production.
  • Q2 2025: Eppendorf Launches New Automated Cell Disruption Platform for Bioprocessing Eppendorf introduced an automated cell disruption platform designed to streamline cell lysis and extraction processes in bioprocessing applications.
  • Q3 2025: Roche Expands Cell Lysis Reagent Portfolio with Launch of FastLys Pro Roche announced the launch of FastLys Pro, a new reagent for rapid and efficient cell lysis, aimed at accelerating workflows in molecular biology labs.
  • Q3 2025: PerkinElmer Secures $30M Funding to Develop Next-Generation Cell Lysis Technologies PerkinElmer received $30 million in funding to advance research and development of next-generation cell lysis technologies for genomics and proteomics applications.

Future Outlook

Cell Lysis Disruption Market Future Outlook

<p>The Cell Lysis and Disruption Market is projected to grow at 8.81% CAGR from 2024 to 2035, driven by advancements in biotechnology and increasing demand for cell-based therapies.</p>

New opportunities lie in:

  • <p>Development of automated cell lysis systems for high-throughput applications.</p><p>Expansion into emerging markets with tailored lysis solutions.</p><p>Partnerships with biotech firms for innovative lysis technologies.</p>

<p>By 2035, the market is expected to solidify its position as a critical component in biopharmaceutical development.</p>

Market Segmentation

Cell Lysis Disruption Market Product Outlook

  • Consumables
  • Instruments

Cell Lysis Disruption Market End-User Outlook

  • Research Laboratories and Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others

Cell Lysis Disruption Market Cell Type Outlook

  • Mammalian Cells
  • Microbial Cells
  • Others

Cell Lysis Disruption Market Technique Outlook

  • Reagent Based
  • Physical Disruption

Report Scope

MARKET SIZE 20246.833(USD Billion)
MARKET SIZE 20257.435(USD Billion)
MARKET SIZE 203517.3(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)8.81% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesAdvancements in microfluidics and automation enhance efficiency in the Cell Lysis and Disruption Market.
Key Market DynamicsTechnological advancements in cell lysis methods drive innovation and competition within the cell lysis and disruption market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Cell Lysis and Disruption Market by 2035?

The projected market valuation for the Cell Lysis and Disruption Market is 17.3 USD Billion by 2035.

What was the market valuation of the Cell Lysis and Disruption Market in 2024?

The overall market valuation was 6.833 USD Billion in 2024.

What is the expected CAGR for the Cell Lysis and Disruption Market during the forecast period 2025 - 2035?

The expected CAGR for the Cell Lysis and Disruption Market during the forecast period 2025 - 2035 is 8.81%.

Which companies are considered key players in the Cell Lysis and Disruption Market?

Key players in the market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Qiagen, and Agilent Technologies.

What are the main techniques used in the Cell Lysis and Disruption Market?

The main techniques in the market include Reagent Based and Physical Disruption, with valuations of 8.5 and 8.8 USD Billion respectively by 2035.

  1. REPORT PROLOGUE
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Primary Research
    3. Secondary Research
    4. Market Size Estimation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    2. Value Chain Analysis
  6. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE
    1. Overview
    2. Reagent Based
  7. Market Estimates & Forecast, by Region, 2020-2027
  8. Market Estimates & Forecast, by Country, 2020-2027
  9. Detergent
  10. Market Estimates & Forecast, by Region, 2020-2027
  11. Market Estimates & Forecast, by Country, 2020-2027
  12. Enzymatic
  13. Market Estimates & Forecast, by Region, 2020-2027
  14. Market Estimates & Forecast, by Country, 2020-2027
    1. Physical Disruption
  15. Market Estimates & Forecast, by Region, 2020-2027
  16. Market Estimates & Forecast, by Country, 2020-2027
  17. Mechanical Homogenization
  18. Market Estimates & Forecast, by Region, 2020-2027
  19. Market Estimates & Forecast, by Country, 2020-2027
  20. Ultrasonic Homogenization
  21. Market Estimates & Forecast, by Region, 2020-2027
  22. Market Estimates & Forecast, by Country, 2020-2027
  23. Pressure Homogenization
  24. Market Estimates & Forecast, by Region, 2020-2027
  25. Market Estimates & Forecast, by Country, 2020-2027
  26. Temperature Treatments
  27. Market Estimates & Forecast, by Region, 2020-2027
  28. Market Estimates & Forecast, by Country, 2020-2027
  29. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT
    1. Overview
    2. Consumables
  30. Market Estimates & Forecast, by Region, 2020-2027
  31. Market Estimates & Forecast, by Country, 2020-2027
  32. Reagents and Kits
  33. Market Estimates & Forecast, by Region, 2020-2027
  34. Market Estimates & Forecast, by Country, 2020-2027
  35. Beads
  36. Market Estimates & Forecast, by Region, 2020-2027
  37. Market Estimates & Forecast, by Country, 2020-2027
  38. Disposables
  39. Market Estimates & Forecast, by Region, 2020-2027
  40. Market Estimates & Forecast, by Country, 2020-2027
    1. Instruments
  41. Market Estimates & Forecast, by Region, 2020-2027
  42. Market Estimates & Forecast, by Country, 2020-2027
  43. Sonicators
  44. Market Estimates & Forecast, by Region, 2020-2027
  45. Market Estimates & Forecast, by Country, 2020-2027
  46. Homogenizers
  47. Market Estimates & Forecast, by Region, 2020-2027
  48. Market Estimates & Forecast, by Country, 2020-2027
  49. French Press
  50. Market Estimates & Forecast, by Region, 2020-2027
  51. Market Estimates & Forecast, by Country, 2020-2027
  52. Microfluidizer
  53. Market Estimates & Forecast, by Region, 2020-2027
  54. Market Estimates & Forecast, by Country, 2020-2027
  55. Others
  56. Market Estimates & Forecast, by Region, 2020-2027
  57. Market Estimates & Forecast, by Country, 2020-2027
  58. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE
    1. Overview
    2. Mammalian Cells
  59. Market Estimates & Forecast, by Region, 2020-2027
  60. Market Estimates & Forecast, by Country, 2020-2027
    1. Microbial Cells
  61. Market Estimates & Forecast, by Region, 2020-2027
  62. Market Estimates & Forecast, by Country, 2020-2027
    1. Others
  63. Market Estimates & Forecast, by Region, 2020-2027
  64. Market Estimates & Forecast, by Country, 2020-2027
  65. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USER
    1. Overview
    2. Research Laboratories and Institutes
  66. Market Estimates & Forecast, by Region, 2020-2027
  67. Market Estimates & Forecast, by Country, 2020-2027
  68. Market Estimates & Forecast, by Region, 2020-2027
  69. Market Estimates & Forecast, by Country, 2020-2027
    1. Others
  70. Market Estimates & Forecast, by Region, 2020-2027
  71. Market Estimates & Forecast, by Country, 2020-2027
  72. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION
    1. Overview
    2. Americas
      1. North America
      2. Latin America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia-Pacific
    5. Middle East & Africa
      1. Middle East
      2. Africa
  73. COMPANY LANDSCAPE
    1. Overview
    2. Competitive Analysis
    3. Market Share Analysis
    4. Major Growth Strategy in the Global Cell Lysis & Disruption Market
    5. Competitive Benchmarking
    6. Leading Players in terms of Number of Developments in the Global Cell Lysis & Disruption Market
    7. Key developments and Growth Strategies
      1. New Product Launch/Service Deployment
      2. Merger & acquisitions
      3. Joint Ventures
    8. Major Players Financial Matrix & Market Ratio
      1. Sales & Operating Income 2020
      2. Major Players R&D Expenditure 2020
    9. Major Players Capital Market Ratio
  74. COMPANY PROFILES
    1. Thermo Fisher Scientific, Inc.
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    2. Merck KGAA
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    3. Bio-Rad Laboratories, Inc.
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    4. Danaher Corporation
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    5. Becton Dickinson & Company
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    6. Cell Signaling Technology, Inc.
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    7. Miltenyi Biotec
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    8. F. Hoffmann–La Roche Ltd
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    9. Qiagen NV
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    10. Qsonica, LLC
      1. Company Overview
      2. Product Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    11. Others
  75. APPENDIX
    1. References
    2. Related Reports
    3.  
  76. LIST OF TABLES
  77. GLOBAL CELL LYSIS & DISRUPTION MARKET SYNOPSIS, 2020-2027
  78. GLOBAL CELL LYSIS & DISRUPTION MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
  79. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  80. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  81. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  82. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  83. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION, 2020-2027 (USD MILLION)
  84. NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  85. NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  86. NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  87. NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  88. US: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  89. US: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  90. US: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  91. US: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  92. CANADA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  93. CANADA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  94. CANADA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  95. CANADA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  96. LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  97. LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  98. LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  99. LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  100. EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  101. EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  102. EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  103. EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  104. WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  105. WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  106. WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  107. WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  108. EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  109. EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  110. EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  111. EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  112. ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  113. ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  114. ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  115. ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  116. MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  117. MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  118. MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
  119. MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    1.  
  120. LIST OF FIGURES
  121. RESEARCH PROCES
  122. MARKET STRUCTURE FOR THE GLOBAL CELL LYSIS & DISRUPTION MARKET
  123. MARKET DYNAMICS FOR THE GLOBAL CELL LYSIS & DISRUPTION MARKET
  124. GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY TECHNIQUE, 2020 (%)
  125. GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY PRODUCT, 2020 (%)
  126. GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY CELL TYPE, 2020 (%)
  127. GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY END USER, 2020 (%)
  128. GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY REGION, 2020 (%)
  129. AMERICAS: CELL LYSIS & DISRUPTION MARKET SHARE BY REGION, 2020 (%)
  130. NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
  131. EUROPE: CELL LYSIS & DISRUPTION MARKET SHARE, BY REGION, 2020 (%)
  132. WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
  133. ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
  134. MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
  135. GLOBAL CELL LYSIS & DISRUPTION MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
  136. THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIALS
  137. THERMO FISHER SCIENTIFIC, INC.: SEGMENTAL REVENUE
  138. THERMO FISHER SCIENTIFIC, INC.: REGIONAL REVENUE
  139. MERCK KGAA: KEY FINANCIALS
  140. MERCK KGAA: SEGMENTAL REVENUE
  141. MERCK KGAA: REGIONAL REVENUE
  142. BIO-RAD LABORATORIES, INC.: KEY FINANCIALS
  143. BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUES
  144. BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE
  145. DANAHER CORPORATION: KEY FINANCIALS
  146. DANAHER CORPORATION: SEGMENTAL REVENUE
  147. DANAHER CORPORATION: REGIONAL REVENUE
  148. BECTON DICKINSON & COMPANY: KEY FINANCIALS
  149. BECTON DICKINSON & COMPANY: SEGMENTAL REVENUE
  150. BECTON DICKINSON & COMPANY: REGIONAL REVENUE
  151. CELL SIGNALING TECHNOLOGY, INC.: KEY FINANCIALS
  152. CELL SIGNALING TECHNOLOGY, INC.: SEGMENTAL REVENUE
  153. CELL SIGNALING TECHNOLOGY, INC.: REGIONAL REVENUE
  154. MILTENYI BIOTEC: KEY FINANCIALS
  155. MILTENYI BIOTEC: SEGMENTAL REVENUE
  156. MILTENYI BIOTEC: REGIONAL REVENUE
  157. F. HOFFMANN–LA ROCHE LTD: KEY FINANCIALS
  158. F. HOFFMANN–LA ROCHE LTD: SEGMENTAL REVENUE
  159. F. HOFFMANN–LA ROCHE LTD: REGIONAL REVENUE
  160. QIAGEN NV: KEY FINANCIALS
  161. QIAGEN NV: SEGMENTAL REVENUE
  162. QIAGEN NV: REGIONAL REVENUE
  163. QSONICA, LLC: KEY FINANCIALS
  164. QSONICA, LLC: SEGMENTAL REVENUE
  165. QSONICA, LLC: REGIONAL REVENUE

Cell Lysis and Disruption Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓